Hyperfine, Inc. reported the third quarter ended September 30, 2022 results: revenue $2.348 million, net income $13.171 million, EPS net loss of $0.19 per share.
“in the third quarter and are continuing to build our pipeline into year-end and beyond.” Third Quarter 2022 Financial Results • Revenues for the third quarter of 2022 were $2.348 million, compared to $0.371 million in the third quarter of 2021. • Gross margin for the third quarter of 2022 was $0.688 million, compared to $(0.338) million in the third quarter of”
R. Scott Huennekens changed role as Executive Chairperson at Hyperfine, Inc..
“R. Scott Huennekens, who has been serving as Interim President and Chief Executive Officer of the Company, will step down from that role effective as of the Appointment Date. Mr. Huennekens will continue to serve as Executive Chairperson of the Board.”
Maria Sainz was appointed as President and Chief Executive Officer at Hyperfine, Inc..
“On October 6, 2022, Hyperfine, Inc. (the 'Company') announced that Maria Sainz, one of the Company’s current directors, was appointed by the Board of Directors of the Company (the 'Board') as President and Chief Executive Officer of the Company, effective as of October 24, 2022”
R. Scott Huennekens was appointed as Interim President and Chief Executive Officer at Hyperfine, Inc..
“the Board of Directors (the “Board”) of Hyperfine, Inc. (the “Company”) appointed R. Scott Huennekens as Interim President and Chief Executive Officer of the Company, effective as of July 29, 2022.”
R. Scott Huennekens was appointed as Interim President and Chief Executive Officer at Hyperfine, Inc..
“On June 29, 2022, the Board appointed R. Scott Huennekens as Interim President and Chief Executive Officer of the Company, effective as of July 29, 2022, to succeed Mr. Scott while the Company searches for Mr. Scott’s replacement.”
Dave Scott resigned as President, Chief Executive Officer and Director at Hyperfine, Inc..
“On June 27, 2022, Dave Scott delivered his resignation as Hyperfine, Inc.’s (the “Company”) President, Chief Executive Officer and a member of the Board of Directors (the “Board”), effective July 29, 2022.”
Benjamin Snedeker was appointed as director at Hyperfine, Inc..
“On August 11, 2021, the Board appointed Mr. Benjamin Snedeker, age 45, to serve as a director on the Board.”
Avi Horev resigned as director at Hyperfine, Inc..
“Additionally, on August 11, 2021, Mr. Avi Horev resigned as a director of the Company.”
Art Cohen was appointed as Chief Executive Officer and director at Hyperfine, Inc..
“On August 11, 2021, the board of directors of the Company (the “Board”) appointed Mr. Art Cohen to serve as the Chief Executive Officer of the Company and as a director, effective immediately.”
Christopher Gaulin resigned as Chief Executive Officer and director at Hyperfine, Inc..
“On August 11, 2021, Mr. Christopher Gaulin resigned as Chief Executive Officer and a director of HealthCor Catalio Acquisition Corp., a Cayman Islands exempted company (the “Company”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.